Literature DB >> 12017745

Risks associated with herbal medicinal products.

E Ernst1, M H Pittler.   

Abstract

Health risks associated with the use of herbal medicinal products (HMPs) are often an emotionally discussed issue. The topic is, however, important not least because of the present popularity of HMPs. This article aims to provide a factual overview of this complex subject. The evidence relating to the toxicity, interactions and quality of a number of HMPs is reviewed. Toxicity data indicate that some HMPs have the potential to cause serious adverse events and fatalities. HMPs affect pharmacokinetic and pharmacodynamic factors and thus cause herb-drug interactions. Reports of HMPs affected by contamination, adulteration or substitution of botanical material have repeatedly caused concern. Asian HMPs are most often implicated. It is concluded that HMPs are not free of risk. More research and more information are required in order to maximize consumers' safety.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12017745     DOI: 10.1046/j.1563-258x.2002.01112.x

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  7 in total

1.  Drug safety aspects of herbal medicinal products.

Authors:  T Wegener; B Deitelhoff; A Silber-Mankowsky
Journal:  Wien Med Wochenschr       Date:  2015-07-17

Review 2.  Contamination and adulteration of herbal medicinal products (HMPs): an overview of systematic reviews.

Authors:  Paul Posadzki; Leala Watson; Edzard Ernst
Journal:  Eur J Clin Pharmacol       Date:  2012-07-29       Impact factor: 2.953

Review 3.  Herbal Medicine in Ischemic Stroke: Challenges and Prospective.

Authors:  Bhakta Prasad Gaire
Journal:  Chin J Integr Med       Date:  2018-04-25       Impact factor: 1.978

4.  Phytochemical Assays of Commercial Botanical Dietary Supplements.

Authors:  Robert Krochmal; Mary Hardy; Susan Bowerman; Qing-Yi Lu; H-J Wang; Rm Elashoff; David Heber
Journal:  Evid Based Complement Alternat Med       Date:  2004-10-06       Impact factor: 2.629

5.  Population awareness of risks related to medicinal product use in Vientiane Capital, Lao PDR: a cross-sectional study for public health improvement in low and middle income countries.

Authors:  Céline Caillet; Chanvilay Sichanh; Lamphone Syhakhang; Cyrille Delpierre; Chanthanom Manithip; Mayfong Mayxay; Maryse Lapeyre-Mestre; Paul N Newton; Anne Roussin
Journal:  BMC Public Health       Date:  2015-06-27       Impact factor: 3.295

6.  Antioxidant, Antiglycation, and Hypoglycaemic Effect of Seriphium plumosum Crude Plant Extracts.

Authors:  Brian K Beseni; Victor P Bagla; Idris Njanje; Thabe M Matsebatlela; Leseilane Mampuru; Matlou P Mokgotho
Journal:  Evid Based Complement Alternat Med       Date:  2017-11-13       Impact factor: 2.629

7.  The safety of over-the-counter niacin. A randomized placebo-controlled trial [ISRCTN18054903].

Authors:  Edward Mills; Jonathan Prousky; Gannady Raskin; Joel Gagnier; Beth Rachlis; Victor M Montori; David Juurlink
Journal:  BMC Clin Pharmacol       Date:  2003-11-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.